{"created":"2024-11-15T01:19:52.167077+00:00","id":2000120,"links":{},"metadata":{"_buckets":{"deposit":"aef76409-e854-46a4-831e-a428c84beedf"},"_deposit":{"created_by":8,"id":"2000120","owners":[8],"pid":{"revision_id":0,"type":"depid","value":"2000120"},"status":"published"},"_oai":{"id":"oai:fmu.repo.nii.ac.jp:02000120","sets":["1731487166818:1731487329839:1731487523656"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"ブレオマイシン誘導性皮膚硬化モデルマウスにおけるリゾホスファチジン酸阻害薬（LPA1,3）の抗線維化効果","subitem_title_language":"ja"}]},"item_1617186385884":{"attribute_name":"Alternative Title","attribute_value_mlt":[{"subitem_alternative_title":"Anti-fibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin","subitem_alternative_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorAlternatives":[{"creatorAlternative":"Ohashi, Takenobu","creatorAlternativeLang":"en"}],"creatorNames":[{"creatorName":"大橋, 威信","creatorNameLang":"ja"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617187087799":{"attribute_name":"Dissertation Number","attribute_value_mlt":[{"subitem_dissertationnumber":"甲第528号"}]},"item_1617187112279":{"attribute_name":"Degree Name","attribute_value_mlt":[{"subitem_degreename":"博士（医学）","subitem_degreename_language":"ja"}]},"item_1617187136212":{"attribute_name":"Date Granted","attribute_value_mlt":[{"subitem_dategranted":"2015-03-24"}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"doctoral thesis","resourceuri":"http://purl.org/coar/resource_type/c_db06"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1111/exd.12752","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2017-07-31"}],"displaytype":"detail","filename":"Thesis_K528_abstract.pdf","format":"application/pdf","mimetype":"application/pdf","url":{"label":"内容要旨","objectType":"abstract","url":"https://fmu.repo.nii.ac.jp/record/2000120/files/Thesis_K528_abstract.pdf"},"version_id":"4f874ea2-0add-42cd-94d6-bcfa0a02ff9f"},{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2020-10-26"}],"displaytype":"detail","filename":"Thesis_K528_fulltext.pdf","format":"application/pdf","license_note":"This is the pre-peer reviewed version of the following article: [Exp Dermatol. 2015 Sep;24(9):698-702], which has been published in final form at [https://doi.org/10.1111/exd.12752]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"本文","objectType":"fulltext","url":"https://fmu.repo.nii.ac.jp/record/2000120/files/Thesis_K528_fulltext.pdf"},"version_id":"1aad4d1d-ca0c-4e5c-8b55-0b4bca826484"}]},"item_1617944105607":{"attribute_name":"Degree Grantor","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_language":"ja","subitem_degreegrantor_name":"福島県立医科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"21601","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_title":"ブレオマイシン誘導性皮膚硬化モデルマウスにおけるリゾホスファチジン酸阻害薬（LPA1,3）の抗線維化効果","item_type_id":"40002","owner":"8","path":["1731487523656"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2017-07-31"},"publish_date":"2017-07-31","publish_status":"0","recid":"2000120","relation_version_is_last":true,"title":["ブレオマイシン誘導性皮膚硬化モデルマウスにおけるリゾホスファチジン酸阻害薬（LPA1,3）の抗線維化効果"],"weko_creator_id":"8","weko_shared_id":-1},"updated":"2025-01-17T02:27:18.957960+00:00"}